Friday, August 22, 2003 3:35:09 PM
Recipient of the PETRONAS National Inventor Award Joins DNA Phenomics' Management Team
Mathavan A. Chandran to Direct Product and Service Development of Life Science Research Company
KUALA LUMPUR, Malaysia – August 8, 2003 - DNA Phenomics Sdn Bhd, a development-stage company focused on the emerging field of phenomics and the discovery of genomic-based diagnostic tests, announces that Mr. Mathavan A. Chandran has agreed to join its management team as Vice President of Business Development.
"I am thrilled Matt will be joining our management team to help implement our very ambitious plans for growth," said Mr. Ezehan Kamaluddin, DNA Phenomics' Chief Operating Officer. "Matt brings broad experience and strong networking ties in a number key areas, with the pharmaceutical market being one of the most important areas given our strategic plans. As the 1995 recipient of the country’s highest honor in science and industry (the PETRONAS and Ministry of Science, Technology and Environment's Inventor of the Year Award), Matt is well known and greatly admired across the region. His success in business and accomplishments in science speak for themselves. We are very fortunate to have Matt on our team."
"As most of us already know, recent developments in the life sciences industry has created a lot of excitement and hopes within the scientific community, among the public, and especially among investors," said Mathavan Chandran. "What impressed me most about DNA Phenomics is their strategic direction and the core competencies of the team members they have assembled. These assets clearly add value and will be recognized as particularly relevant in the commercial world. This opportunity is definitely not to be missed."
Mathavan A. Chandran began his career in 1992 as a research and development chemist at METACORP BHD, the largest inorganic chemical producer in Malaysia. In 1995, Matt became the Regional Business Development Manager (chemical sector) for Peregrine International, a Hong Kong based direct investment company. He was jointly responsible for conceptualizing, evaluating, implementing, and advising start up operations, while monitoring Peregrine’s business plans across the Asia-Pacific region. Subsequently, he worked for the Belgian petrochemical-pharmaceutical multinational, UCB Pharma, as the Regional Sales and Marketing Manager for the Specialty Chemicals Business Unit in Asia-Pacific. More recently, Matt has served as principal consultant for a number of large multinationals covering ICT, financial institutions, automotive, and telecommunication. In the last two years, Matt has fostered several early stage biotechnology and bioinformatics initiatives.
66fan
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM